Asparaginase is a substance capable of reducing the production of a substance called asparagine, necessary for the development of cancer cells that occur in case of leukemia.
Thus, this substance is produced in the form of a drug under the trade name Elspar for the treatment of acute lymphocytic leukemia, in the hospital, especially in children being treated with other neoplastics.
- Asparaginase is not available for sale to the public.
- And it can only be used in the treatment of cancer in the hospital.
- By a team of health professionals.
- Upon indication of the oncologist.
The use of asparaginase varies depending on the type of treatment recommended by the oncologist, however, the most commonly used treatment regimen is:
In some cases, this medicine may also be given in a single injection into the muscle, however, in these cases, the amount of medicine should not exceed 2 ml.
This treatment should be done 3 times a week
The main side effects of asparaginase include nausea, vomiting, loss of appetite, dizziness, excessive fatigue and generalized itching.
Asparaginase is countered in patients with pancreatitis, a history of pancreatic problems or allergy to one of the ingredients of the formula.